Home » News from science » Seppic unveils “The tail-ored pet care collection”: an inspirational formulation kit for animal hygiene and care

Seppic unveils “The tail-ored pet care collection”: an inspirational formulation kit for animal hygiene and care

Following the launch of its dedicated line of ingredients Sepifriend™ for companion animals, Seppic unveils “The tail-ored pet care collection.” This new kit of six formulations provides manufacturers with technical evidence and inspiration needed to address the specific care and hygiene requirements of pets.

With more than half of the global population estimated to have a pet at home (1)  and animals playing an 1 increasingly central role in households, the demand for grooming products has reached new heights. By emphasizing the safety of formulations and the natural origin of ingredients, the demand aligns with the sensory standards of the cosmetics industry.

However, animal physiology requires a dedicated approach as pets skin is 3 to 5 times thinner than human skin and maintains a more neutral pH. To answer these specific needs, Seppic has developed a 6-formula collection with its Sepifriend™ ingredients, that balances high naturality with regulatory compliance for a 3-steps care and hygiene routine. These ingredients have been rigorously tested in vitro on Reconstructed Canine Epidermis, demonstrating no impact on tissue viability and suggesting their suitability for leave-on or rinse-off applications.

“The tail-ored pet care collection” demonstrates of Sepifriend™ ingredients effectiveness through a premium three-step routine for dogs, cats or horses:
● Step 1: cleansing sensitive areas (soothing eye contour pet cleanser, gentle pet ear lotion)
● Step 2: coat & skin hygiene (ultra-mild moisturizing & soothing pet shampoo, no-rinse cleansing & purifying foam)
● Step 3: care for specific areas (sprayable shine & coat care, nose & paw balm with centella asiatica)

This kit features high-performance functional ingredients, including sulfate-free foamers, solubilizers, rheology modifiers, emulsifiers and emollients, to create textures with optimal viscosity and sensory profiles adapted to both the pet’s comfort and the owner’s expectations. It also highlights Sepifriend™ active ingredients, which deliver benefits such as long-lasting moisturization, soothing effects, accelerated skin repair and dermo-purifying properties.
This collection demonstrates Seppic’s ability to deliver high-naturality formulas ready to meet the evolving demands of the global market.

(1) Nielseniq.com

 

Seppic in brief
A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes for 80 years a wide range of specialty ingredients for
cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products. Seppic employs close to 900 people worldwide, including
110 employees dedicated to innovation who develop effective ingredients with unique characteristics. Present in 100 countries
through its subsidiaries and its network of distributors, Seppic aims to help everyone live well, and in good health in a healthy
environment. www.seppic.com

About Air Liquide Healthcare
Air Liquide Healthcare is a world leader in home healthcare services, medical gases and specialty ingredients. Our 15,000 employees
support 2.3 million chronic patients and provide medical gases and related services to 20,000 hospitals and care facilities, as well as to
110,000 healthcare professionals customers. Committed to working alongside professionals and health institutions, our approach is
based on the principles of value in Healthcare, which aims to improve the benefits experienced by patients and to facilitate the work of
caregivers, at the best cost for society, thus contributing to a more efficient and sustainable system.

Oxygen, nitrogen, hydrogen, and many other essential small molecules are the invisible pillars of our world and our lives. They have
been at the core of the Group’s activities since its creation in 1902.
A world leader in gases, technologies and services for industry and healthcare, Air Liquide acts as the backbone of numerous economic
sectors, serving 4.3 million customers and patients across 59 countries with approximately 65,000 employees. With revenues close to
27 billion euros in 2025, Air Liquide combines strong performance and useful growth.
The Group is a leader with a diversified, resilient business model and a strong local footprint across the globe. Through deep
engineering expertise and technological innovation, Air Liquide provides scalable solutions that enhance industrial efficiency,
accelerate decarbonization, and strengthen value chains. Strategically exposed to growth markets and megatrends, the Group
accompanies major industrial and societal transformations to create long term added value and build a sustainable future.
Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50,
FTSE4Good, and Dow Jones Best-in-Class Europe Index indexes.

Trusted by

40 years connecting the world of science for industry

Our journals:

Login